trending Market Intelligence /marketintelligence/en/news-insights/trending/038o7vlllhii23egk9gdjq2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Cytori Therapeutics falls out of compliance with Nasdaq listing requirements

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Cytori Therapeutics falls out of compliance with Nasdaq listing requirements

Cytori Therapeutics Inc. said it fell out of compliance with the Nasdaq Stock Market LLC's listing requirements.

The Nasdaq said in a notice that the San Diego-based company failed to maintain a minimum bid price of $1 per share for the last 30 consecutive business days.

Cytori Therapeutics has until Feb. 25, 2019, to regain compliance with the listing requirement, the company said in an SEC filing.

The company had recently regained compliance with Nasdaq's minimum bid price rule after implementing a 1-for-10 reverse stock split.